Genetic variant reclassification: a narrative review - Top-Institutions - MDSpire

Genetic variant reclassification: a narrative review

  • By

  • Giuseppina Rosaria Umano

  • Grazia Cirillo

  • Anna Di Sessa

  • Raffaella D’Ausilio

  • Flavia Guarino

  • Stella Fusco

  • Pierluigi Marzuillo

  • Giulia Rondinelli

  • Emanuele Miraglia del Giudice

  • December 30, 2025

  • 0 min

Share

Top Institutions in Pathology

Brief introduction explaining scope and methodology.

  • #1

    Broad Institute of MIT and Harvard
    Broad Institute of MIT and Harvard

    Cambridge, MA

    Key Differentiators

    • Genomics
    • Medical Genetics
    • Bioinformatics

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Medical Genetics
    • Clinical Genomics
    • Oncology

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Medical Genetics
    • Genomic Medicine
    • Bioinformatics

  • #4

    National Human Genome Research Institute (NHGRI), NIH
    National Human Genome Research Institute (NHGRI), NIH

    Bethesda, MD

    Key Differentiators

    • Genomics Research
    • Medical Genetics
    • Bioinformatics

  • #5

    Children’s Hospital of Philadelphia (CHOP)
    Children’s Hospital of Philadelphia (CHOP)

    Philadelphia, PA

    Key Differentiators

    • Pediatric Genetics
    • Clinical Genomics
    • Bioinformatics

Original Source(s)

Genetic variant reclassification: a narrative review

  • by Giuseppina Rosaria Umano, Grazia Cirillo, Anna Di Sessa, Raffaella D’Ausilio, Flavia Guarino, Stella Fusco, Pierluigi Marzuillo, Giulia Rondinelli, Emanuele Miraglia del Giudice

  • December 30, 2025

Related Content

Second Primary Cancer Risk Shifts Over Time

US registry study finds overall declines but rising risk in lung, melanoma, and older survivor groups

Diverse Clinical and Molecular Characteristics of Advanced POLE-Mutated Endometrial Carcinoma: Emphasis on Aggressive Variants and Co-Occurring Mutations

Trends in Intrahepatic and Bile Duct Cancers in the United States from 1999 to 2023